
Phreesia Renews Contract with CMS Innovation Center Through 2029
Key Highlights
- Phreesia’s contract with CMS Innovation Center extended through 2029.
- PAM performance measure used in CMS’s alternative payment models.
- Supports Kidney Care Choices Model improving care for 200,000 CKD patients.
- PAM scores increased by 8.8 points; 12.8-point increase among transplant patients.
- PAM adoption helps reduce disparities among disadvantaged patient populations.
Source: Business Wire
Notable Quotes
“ Care teams drove significant increases in PAM scores...meaning tens of thousands of kidney care patients are taking a more active role in their care. ”
Hilary Hatch, PhD, Chief Clinical Officer at Phreesia
“ Patient activation is powerful, I’ve used it in my own practice...we’ll see continued improvements in outcomes—as well as cost reductions—in future years of the KCC Model. ”
Alan Glaseroff, MD, Co-Founder at Stanford Coordinated Care